Citizens Financial Group’s Ionis Pharmaceuticals IONS Stock Holding History

Citizens Financial Group’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-298	Closed	-$18K	–	558
2020 Q2	$18K	Hold	298	–	–	﹤0.01%	644
2020 Q1	$14K	Hold	298	–	–	﹤0.01%	674
2019 Q4	$18K	Hold	298	–	–	﹤0.01%	635
2019 Q3	$18K	Buy	+298	New	+$19.4K	﹤0.01%	477

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Citizens Financial Group's IONS Position: Q3 2020 in Review

Citizens Financial Group sold out of Ionis Pharmaceuticals (IONS) in Q3 2020, closing a stake of 298 shares — an estimated $18K sold.

Citizens Financial Group first reported a position in IONS in Q3 2019 and held it in 4 quarters. The position peaked at $18K in Q2 2020. 367 funds tracked by Wall St. Rank hold IONS as of Q3 2020.

Citizens Financial Group reported no remaining Ionis Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Citizens Financial Group sold 298 Ionis Pharmaceuticals shares in Q3 2020, an estimated $18K.
Citizens Financial Group first reported a position in Ionis Pharmaceuticals in Q3 2019 and held it in 4 quarters.
Citizens Financial Group's Ionis Pharmaceuticals position peaked at $18K in Q2 2020.
367 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.